UnknownNot applicableNCT01546805
Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Studying Hemifacial spasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Joseph's Healthcare Hamilton
- Principal Investigator
- John Harvey, MDSt Joseph's Hospital Hamilton
- Intervention
- Zinc Supplement(drug)
- Enrollment
- 40 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2013
Study locations (2)
- St Joseph's Hospital Hamilton, Hamilton, Ontario, Canada
- Carrot Eye Centre, Mississauga, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01546805 on ClinicalTrials.govOther trials for Hemifacial spasm
Additional recruiting or active studies for the same condition.